Drug information for MITOMYCIN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
INJECTABLE; INJECTION 20MG/VIAL Discontinued   MITOMYCIN Mitomycin HOSPIRA 64106
INJECTABLE; INJECTION 20MG/VIAL Prescription AP  MITOMYCIN Mitomycin BEDFORD 64117
INJECTABLE; INJECTION 5MG/VIAL Prescription AP  MITOMYCIN Mitomycin BEDFORD   "
INJECTABLE; INJECTION 20MG/VIAL Prescription AP (Reference Drug) MITOMYCIN Mitomycin ACCORD HLTHCARE 64144
1998-04-30 Letter
INJECTABLE; INJECTION 40MG/VIAL Prescription AP (Reference Drug) MITOMYCIN Mitomycin ACCORD HLTHCARE   "
INJECTABLE; INJECTION 5MG/VIAL Prescription AP (Reference Drug) MITOMYCIN Mitomycin ACCORD HLTHCARE   "
INJECTABLE; INJECTION 20MG/VIAL Prescription AP  MITOMYCIN Mitomycin BAXTER HLTHCARE 64180
1999-12-23 Letter
INJECTABLE; INJECTION 5MG/VIAL Prescription AP  MITOMYCIN Mitomycin BAXTER HLTHCARE   "

Drug Adverse Effects information for MITOMYCIN

Role code Indications Reaction # Reports
PS ANAL CANCER DIARRHOEA 2
PS ANAL CANCER HAEMOLYTIC URAEMIC SYNDROME 2
PS ANAL CANCER PYREXIA 2
PS ANAL CANCER STOMATITIS 2
PS ANAL CANCER THROMBOTIC THROMBOCYTOPENIC PURPURA 2
PS ANAL CANCER TRISMUS 2
PS ANAL CANCER WEIGHT DECREASED 2
PS ANAL CANCER RECURRENT HAEMOLYTIC URAEMIC SYNDROME 2
PS ANAL CANCER RECURRENT THROMBOTIC THROMBOCYTOPENIC PURPURA 2
PS BLADDER CANCER BLISTER 1
PS BLADDER CANCER CONTRACTED BLADDER 1
PS BLADDER CANCER CYSTITIS 1
PS BLADDER CANCER PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
PS BLADDER CANCER RASH GENERALISED 2
PS BLADDER CANCER URINARY TRACT INFECTION 1
PS BLADDER TRANSITIONAL CELL CARCINOMA CHEMICAL CYSTITIS 2
PS BLADDER TRANSITIONAL CELL CARCINOMA SUPRAPUBIC PAIN 2
PS CONJUNCTIVAL MELANOMA BLINDNESS 1
PS CONJUNCTIVAL MELANOMA EYE DISORDER 1
PS CONJUNCTIVAL MELANOMA OFF LABEL USE 1
PS HEPATIC NEOPLASM MALIGNANT BILIARY TRACT DISORDER 4
PS HEPATIC NEOPLASM MALIGNANT BILOMA 2
PS HEPATIC NEOPLASM MALIGNANT BLOOD CHLORIDE DECREASED 2
PS HEPATIC NEOPLASM MALIGNANT BLOOD SODIUM DECREASED 2
PS HEPATIC NEOPLASM MALIGNANT GASTRIC STENOSIS 3
PS HEPATIC NEOPLASM MALIGNANT PLATELET COUNT DECREASED 2
PS HEPATIC NEOPLASM MALIGNANT WHITE BLOOD CELL COUNT DECREASED 2
PS MALIGNANT MELANOMA CYSTOID MACULAR OEDEMA 4
PS METASTASES TO LYMPH NODES HAEMOLYTIC URAEMIC SYNDROME 2
PS METASTASES TO LYMPH NODES THROMBOTIC THROMBOCYTOPENIC PURPURA 2
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FAILURE 1
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 1
PS PRODUCT USED FOR UNKNOWN INDICATION OFF LABEL USE 2
PS PRODUCT USED FOR UNKNOWN INDICATION PANCREATITIS ACUTE 1
PS PRODUCT USED FOR UNKNOWN INDICATION PSEUDOCYST 1
PS TRABECULECTOMY CORNEAL EPITHELIAL MICROCYSTS 1
PS TRABECULECTOMY OFF LABEL USE 1
PS TRANSITIONAL CELL CARCINOMA PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
PS TRANSITIONAL CELL CARCINOMA RASH GENERALISED 1
PS VISUAL ACUITY REDUCED CORNEAL SCAR 2
PS VISUAL ACUITY REDUCED VISUAL ACUITY REDUCED 2
SS ANAL CANCER HAEMOLYTIC URAEMIC SYNDROME 4
SS ANAL CANCER RASH 2
SS ANAL CANCER THROMBOCYTOPENIA 2
SS ANAL CANCER THROMBOTIC THROMBOCYTOPENIC PURPURA 2
SS ANAL CANCER RECURRENT HAEMOLYTIC URAEMIC SYNDROME 2
SS ANAL CANCER RECURRENT THROMBOTIC THROMBOCYTOPENIC PURPURA 2
SS BLADDER TRANSITIONAL CELL CARCINOMA CHEMICAL CYSTITIS 1
SS BREAST CANCER CARDIAC CIRRHOSIS 20
SS BREAST CANCER HEPATIC CIRRHOSIS 30
SS BREAST CANCER HEPATIC FAILURE 94
SS BREAST CANCER LIVER SCAN ABNORMAL 30
SS BREAST CANCER METASTATIC ASCITES 14
SS BREAST CANCER METASTATIC HEPATIC CIRRHOSIS 86
SS BREAST CANCER METASTATIC HEPATIC FAILURE 86
SS BREAST CANCER METASTATIC PORTAL HYPERTENSION 14
SS CHEMOTHERAPY HEPATIC FAILURE 2
SS CHEMOTHERAPY HEPATIC NEOPLASM MALIGNANT 4
SS CHEMOTHERAPY NEOPLASM PROGRESSION 4
SS CHEMOTHERAPY OESOPHAGEAL VARICES HAEMORRHAGE 2
SS CHEMOTHERAPY OFF LABEL USE 4
SS CHEMOTHERAPY TUMOUR THROMBOSIS 4
SS HORMONE REPLACEMENT THERAPY CARDIAC CIRRHOSIS 1
SS HORMONE REPLACEMENT THERAPY HEPATIC FAILURE 1
SS HORMONE THERAPY CARDIAC CIRRHOSIS 9
SS HORMONE THERAPY HEPATIC FAILURE 9
SS METASTASES TO LYMPH NODES HAEMOLYTIC URAEMIC SYNDROME 2
SS METASTASES TO LYMPH NODES THROMBOTIC THROMBOCYTOPENIC PURPURA 2
SS PERCUTANEOUS ETHANOL INJECTION THERAPY HEPATIC NEOPLASM MALIGNANT 1
SS PERCUTANEOUS ETHANOL INJECTION THERAPY NEOPLASM PROGRESSION 1
SS PERCUTANEOUS ETHANOL INJECTION THERAPY OFF LABEL USE 1
SS PERCUTANEOUS ETHANOL INJECTION THERAPY TUMOUR THROMBOSIS 1
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATITIS 2
SS REGIONAL CHEMOTHERAPY HEPATIC FAILURE 1
SS REGIONAL CHEMOTHERAPY HEPATIC NEOPLASM MALIGNANT 2
SS REGIONAL CHEMOTHERAPY NEOPLASM PROGRESSION 2
SS REGIONAL CHEMOTHERAPY OESOPHAGEAL VARICES HAEMORRHAGE 1
SS REGIONAL CHEMOTHERAPY OFF LABEL USE 2
SS REGIONAL CHEMOTHERAPY TUMOUR THROMBOSIS 2
SS SARCOMA ELECTROLYTE IMBALANCE 7
SS SARCOMA EMBOLISM VENOUS 7
SS SARCOMA WOUND COMPLICATION 13
C ABDOMINAL PAIN BLADDER CANCER 1
C ANAL CANCER PHARYNGEAL INFLAMMATION 1
C BLADDER CANCER BLADDER CANCER 1
C CROHN'S DISEASE BLADDER CANCER 3
C DIARRHOEA BLADDER CANCER 1
C GLAUCOMA CORNEAL EROSION 1
C GLAUCOMA INTRAOCULAR PRESSURE INCREASED 1
C NUTRITIONAL SUPPORT ANAPHYLACTIC SHOCK 1
Ads by Google